Results 121 to 130 of about 2,249,082 (267)

Current Perspective on Human Milk Derived Vesicles and Their Potential Therapeutic Use: A Scoping Review. [PDF]

J Extracell Vesicles
Hrasnova P, Matea CT, Gombos P, Torbahn G, Marl A, Ginzel M, Gsöllpointner M, Gimona M, Rohde E, Haiden N, van Herwijnen M, Wauben M, Weghuber D, Meisner-Kober N.   +13 more
europepmc   +1 more source

Secretory Phospholipase A2 in Patients With Sickle Cell Disease Hospitalized for Vaso‐Occlusive Pain Episodes

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Secretory phospholipase A2 (sPLA2) is an inflammatory mediator linked to acute chest syndrome (ACS) in sickle cell disease (SCD), a serious complication that can develop during an acute vaso‐occlusive pain episode (VOE). Plasma sPLA2 levels have been proposed as a potential biomarker for predicting ACS onset.
Rawan Korman, Maria Yasmine, Dunia Hatabah, Noor Alzraikat, Frank Harris, Lou Ann Brown, Satheesh Chonat, Nitya Bakshi, Chris A. Rees, Carlton Dampier, Claudia R. Morris   +10 more
wiley   +1 more source

The therapeutic use of music for chronic pain: a psychological and neurobiological perspective. [PDF]

Front Pain Res (Lausanne)
Fernández-Dueñas V, Rodríguez-Fornells A, Grau-Sánchez J.   +2 more
europepmc   +1 more source

Impact of Japan's 2024 Physician Work‐Style Reform on Pediatric Hematology–Oncology: Educational Implications in a 2‐Year Survey

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Japan's 2024 physician work‐style reform introduced legally binding limits on physicians’ working hours, but its impact on education and workforce sustainability in pediatric hematology–oncology (PHO) remains unclear. Procedure We conducted a repeated cross‐sectional study with structured quantitative items and free‐text responses ...
Kiyohiko Kaizu, Masaharu Akiyama, Toshikazu Itabashi, Jun Hayakawa, Takahiro Kikuchi, Ryohei Fukunaga, Katsuyoshi Koh, Takahiro Ueda   +7 more
wiley   +1 more source

Amplification, purification, and lyophilization of mycobacteriophages for therapeutic use. [PDF]

Microbiol Spectr
Viland MD, Abad L, Jacobs-Sera D, Freeman KG, Russell DA, Garlena RA, Mowry E, Yu S, Lauer MJ, Vehring R, Guerrero-Bustamante C, Hatfull GF.   +11 more
europepmc   +1 more source

Infant Embryonal CNS Tumors: Molecular Insights and Treatment Considerations for Contemporary Pediatric Neuro‐Oncology

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Embryonal tumors comprise the majority of malignant central nervous system (CNS) neoplasms diagnosed in children under 3 years of age. Compared with their counterparts in older children, these tumors exhibit distinct molecular biology and a more aggressive clinical phenotype, while their management is complicated by the heightened ...
Sudarshawn Damodharan, Mariah Wright‐Nadkarni, Mohamed S. Abdelbaki, Girish Dhall   +3 more
wiley   +1 more source

Novel therapeutic use of nemolizumab for refractory chronic scalp dysesthesia. [PDF]

JAAD Case Rep
Kuan L, Mah T, Chansky PB.
europepmc   +1 more source

Potential therapeutic use of Indian medicinal plants for preeclampsia management. [PDF]

J Ayurveda Integr Med
Wazib S, Ambardar Y, Quasimi H, Alam S, Afghan S, Alam MI.   +5 more
europepmc   +1 more source

A Bibliometric Analysis of Publications in Uremic Toxins From 1991 to 2024

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Uremic toxins are a growing area of research in nephrology, with significant implications in the progression and treatment of chronic kidney disease (CKD) and the management of end‐stage kidney disease (ESKD). This bibliometric analysis aims to evaluate the global research trends, key contributors, and the impact of publications in ...
Yuh‐Shan Ho, Karim M. Soliman, Wisit Cheungpasitporn, Wannasit Wathanavasin, Ahmed Daoud, Ahmed I. Kamal, Balázs Szamosfalvi, Tibor Fülöp   +7 more
wiley   +1 more source

Editorial-Translation of purinergic drugs into therapeutic use. [PDF]

Purinergic Signal
Kennedy C.
europepmc   +1 more source